1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for TNXP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2012. Start Trial.
Date Value
September 11, 2026 -61.97%
September 10, 2026 -54.50%
September 09, 2026 -50.31%
September 08, 2026 -47.96%
September 04, 2026 -50.06%
September 03, 2026 -51.73%
September 02, 2026 -51.63%
September 01, 2026 -52.82%
August 31, 2026 -52.41%
August 28, 2026 -55.89%
August 27, 2026 -57.86%
August 26, 2026 -59.89%
August 25, 2026 -60.51%
August 24, 2026 -67.22%
August 21, 2026 -64.99%
August 20, 2026 -65.63%
August 19, 2026 -65.15%
August 18, 2026 -68.41%
August 17, 2026 -75.35%
August 14, 2026 -78.67%
August 13, 2026 -79.70%
August 12, 2026 -79.97%
August 11, 2026 -72.56%
August 10, 2026 -72.92%
August 07, 2026 -74.36%
Date Value
August 06, 2026 -74.46%
August 05, 2026 -76.39%
August 04, 2026 -74.89%
August 03, 2026 -72.66%
July 31, 2026 -73.43%
July 30, 2026 -73.87%
July 29, 2026 -77.69%
July 28, 2026 -78.99%
July 27, 2026 -79.15%
July 24, 2026 -77.91%
July 23, 2026 -76.67%
July 22, 2026 -76.34%
July 21, 2026 -74.37%
July 20, 2026 -76.59%
July 17, 2026 -73.66%
July 16, 2026 -73.70%
July 15, 2026 -73.73%
July 14, 2026 -74.15%
July 13, 2026 -71.36%
July 10, 2026 -70.42%
July 09, 2026 -66.03%
July 08, 2026 -64.06%
July 07, 2026 -64.14%
July 06, 2026 -64.18%
July 02, 2026 -64.91%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Exelixis, Inc. 43.64%
Inovio Pharmaceuticals, Inc. -52.83%
Heron Therapeutics, Inc. -75.35%
ACADIA Pharmaceuticals, Inc. 15.00%
Alnylam Pharmaceuticals, Inc. -46.93%